Working with TipRanks
Follow Us
Stocks
ETFs
Options
Commodities
Crypto
Currency
Research Tools
Calendars
Economic Indicators
Calculators
Education
About Us
Working with TipRanks
Follow Us
Idexx Laboratories (IDXX)
NASDAQ:IDXX
Idexx Laboratories (IDXX) Stock Price & Analysis
1,883 Followers
IDXX Stock Chart & Stats
Day’s Range$0 - $0
52-Week Range$372.50 - $583.39
Previous Close$475.82
Volume547.95K
Average Volume (3M)434.69K
Market Cap
$39.54B
Enterprise Value$40.32B
Total Cash (Recent Filing)$331.70M
Total Debt (Recent Filing)$1.12B
Price to Earnings (P/E)46.1
Beta1.42
Next Earnings
Aug 06, 2024EPS Estimate
$2.92Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)10.32
Shares Outstanding82,587,328
10 Day Avg. Volume562,640
30 Day Avg. Volume434,685
Standard Deviation0.10
R-Squared0.45
Alpha0.00444
Financial Highlights & Ratios
Price to Book (P/B)37.61
Price to Sales (P/S)47.43
Price to Cash Flow (P/CF)38.90
P/FCF Ratio37.80
Enterprise Value/Market CapN/A
Enterprise Value/Revenue11.24
Enterprise Value/Gross Profit14.88
Enterprise Value/Ebitda33.77
Forecast
1Y Price Target
$589.17Price Target Upside22.59% Upside
Rating ConsensusModerate Buy
Number of Analyst Covering7
Idexx Laboratories News
PremiumPre-Earnings
Is IDXX a Buy, Before Earnings?
Bulls Say, Bears Say
Bulls Say
Analyst's RecommendationAnalyst reiterates a Buy on IDXX, citing an improved end-market outlook and robust revenue growth expectations.
Financial PerformanceHigher gross margins were recorded, suggesting financial strength and potential stock catalysts.
Product LaunchThe company's launch of the InVue Dx analyzer is on track, with potential to contribute to growth.
Bears Say
Clinical Visit Trends1Q vet visits down -2.3%, indicating a continuation of negative clinic volume trends.
Financial PerformanceExpectations of roughly flat clinical vet visit growth for the year are challenged by the actual downturn in visits.
Revenue GuidanceIDEXX Laboratories Inc. reported slightly lower 1Q24 CAG Dx recurring revenue and reduced its 2024 CAG Dx recurring revenue guidance.
---
Ownership Overview
1.53% Insiders
28.69% Mutual Funds
30.05% Other Institutional Investors
39.73% Public Companies and Individual Investors
Risk Analysis
Main Risk Category
Legal & RegulatoryLitigation, compliance, new legislation, and taxation risks
Website Traffic
Sorry, No Data AvailableThere is no website visitor data available for this stock.
---
IDXX FAQ
What was Idexx Laboratories’s price range in the past 12 months?
Idexx Laboratories lowest stock price was $372.50 and its highest was $583.39 in the past 12 months.
What is Idexx Laboratories’s market cap?
Currently, no data Available
When is Idexx Laboratories’s upcoming earnings report date?
Idexx Laboratories’s upcoming earnings report date is Aug 06, 2024 which is in 92 days.
How were Idexx Laboratories’s earnings last quarter?
Idexx Laboratories released its earnings results on May 01, 2024. The company reported $2.81 earnings per share for the quarter, beating the consensus estimate of $2.712 by $0.098.
Is Idexx Laboratories overvalued?
According to Wall Street analysts Idexx Laboratories’s price is currently Undervalued.
Does Idexx Laboratories pay dividends?
Idexx Laboratories does not currently pay dividends.
What is Idexx Laboratories’s EPS estimate?
Idexx Laboratories’s EPS estimate is $2.92.
How many shares outstanding does Idexx Laboratories have?
Idexx Laboratories has 83,089,380 shares outstanding.
What happened to Idexx Laboratories’s price movement after its last earnings report?
Idexx Laboratories reported an EPS of $2.81 in its last earnings report, beating expectations of $2.712. Following the earnings report the stock price went down -5.017%.
Which hedge fund is a major shareholder of Idexx Laboratories?
Among the largest hedge funds holding Idexx Laboratories’s share is Iron Triangle Partners LP. It holds Idexx Laboratories’s shares valued at 42M.
---
Idexx Laboratories Stock Smart Score
Neutral
1
2
3
4
5
6
7
8
9
10
Analyst Consensus
Moderate Buy
Average Price Target:
$589.17 (22.59% Upside)
$589.17 (22.59% Upside)
Blogger Sentiment
Bullish
IDXX Sentiment 83%
Sector Average 70%
Sector Average 70%
Hedge Fund Trend
Decreased
By 230.3K Shares
Last Quarter.
Last Quarter.
Insider Transactions
Sold Shares
Worth $25.2M over
the Last 3 Months
the Last 3 Months
Crowd Wisdom
Positive
Last 7 Days ▲ 0.9%
Last 30 Days ▲ 0.7%
Last 30 Days ▲ 0.7%
News Sentiment
Very Bullish
Bullish news 100%
Bearish news 0%
Bearish news 0%
Technicals
SMA
Negative
20 days / 200 days
Momentum
1.80%
12-Months-Change
Fundamentals
Return on Equity
71.91%
Trailing 12-Months
Asset Growth
19.41%
Trailing 12-Months
Company Description
Idexx Laboratories
Maine-based IDEXX Laboratories, Inc. develops, manufactures, and distributes products and services for the animal veterinary, livestock and poultry, dairy and water testing markets. It operates through the Companion Animal Group; Water Quality Products; Livestock, Poultry and Dairy; and Other segments.
---
IDXX Earnings Call
Q1 2024
0:00 / 0:00
---
IDXX Revenue Breakdown
34.93% Reference laboratory diagnostic and consulting services
32.46% IDEXX VetLab consumables
9.41% Rapid assay products
7.63% Veterinary software, services and diagnostic imaging systems
15.58% Other
---
IDXX Stock 12 Months Forecast
Average Price Target
$589.17
▲(22.59% Upside)
Technical Analysis
Best Analysts Covering IDXX
1 Year
1 Year Success Rate
11/16 ratings generated profit
1 Year Average Return
+21.92%
reiterated a buy rating 3 months ago
Copying Erin Wright's trades and holding each position for 1 Year would result in 68.75% of your transactions generating a profit, with an average return of +21.92% per trade.
---